ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 151 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $358,972 | -22.7% | 366,298 | +9.6% | 0.01% | -10.0% |
| Q2 2023 | $464,631 | +10.7% | 334,267 | +26.6% | 0.01% | +11.1% |
| Q1 2023 | $419,906 | -85.6% | 264,092 | -43.5% | 0.01% | -86.8% |
| Q4 2022 | $2,910,874 | +46.0% | 467,235 | +57.0% | 0.07% | +36.0% |
| Q3 2022 | $1,994,000 | +15.5% | 297,658 | +9.6% | 0.05% | +11.1% |
| Q2 2022 | $1,727,000 | +21.5% | 271,543 | +784.5% | 0.04% | -84.7% |
| Q2 2017 | $1,421,000 | – | 30,700 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |